Liao Pei-Ju, Hsu Kuang-Hung, Chiou Hung-Yi, Chen Chien-Jen, Lee Chih-Hung, 2021, “Joint effects of genomic markers and urinary methylation capacity associated with inorganic arsenic metabolism on the occurrence of cancers among residents in arseniasis-endemic areas: A cohort subset with average fifteen-year follow-up”, Biomedical Journal, 44(6), S218-S225. (SCIE)
Tsai TL, Kuo CC, Hsu LI, Tsai SF, Chiou HY, Chen CJ*, Hsu KH, Wang SL, 2021, “Association between arsenic exposure, DNA damage, and urological cancers incidence: A long-term follow-up study of residents in an arseniasis endemic area of northeastern Taiwan.”, Chemosphere, 266, 129094. (SCIE)
Argirion I, Pfeiffer RM, Lam TK, O'Brien TR, Yu K, McGlynn KA, Petrick JL, Pinto L, Chen CJ, Lee MH, Hildesheim A, Yang HI, Koshiol J, 2021, “Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B.”, Scientific reports, 11(1), 21194. (SCIE)
Pan WC, Yeh SY, Wu CD, Huang YT, Chen YC, Chen CJ, Yang HI, 2021, “Association between Traffic Count and Cardiovascular Mortality: A Prospective Cohort Study in Taiwan.”, Journal of Epidemiology, 31(5), 343-349. (SCIE)
Yu KJ, Hsu WL, Chiang CJ, Chen TC, Liu Z, Lou PJ, Diehl S, Goldstein AM, Chen CJ, Wang CP, Hildesheim A, 2021, “Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.”, Cancer, ONLINE, ONLINE-ONLINE. (SCIE)
Wei C, Lee CC, Hsu TC, Hsu WT, Chan CC, Chen SC, Chen CJ, 2021, “Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.”, Epidemiology and infection, 149, e1. (SCIE)
Yang HI, Chen CJ, 2021, “Epidemiology and Natural History of Hepatitis B Virus Infection: Time-Dependent Driving Factors of Chronic Hepatitis B Progression”, editor(s): Kao, J. H., Hepatitis B Virus and Liver Disease, pp. 143-167, Singapore: Springer.
Chen CJ*, You SL, Hsu WL, Yang HI, Lee MH, Chen HC, Chen YY, Liu J, Hu HH, Lin YJ, Chu YJ, Huang YT, Chiang CJ, Chien YC, 2021, “Epidemiology of Virus Infection and Human Cancer.”, editor(s): T.-C. WuMei-Hwei ChangKuan-Teh Jeang, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, pp. 217, 13-45, Switzerland: Springer, Cham.
Lee MH, Huang YH, Coghill AE, Liu Z, Yu KJ, Hsu WL, Chien YC, Wang CP, Chen TC, Chen CJ, Hildesheim A, 2021, “Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.”, JOURNAL OF INFECTIOUS DISEASES, 223(3), 441-444. (SCIE)
Liu PC, Chan C, Huang YH, Chen YJ, Liao SF, Lin YJ, Huang C, Lu SN, Jen CL, Wang LY, Yang HI, Shen CY, Chen CJ, Lee MH, 2021, “Genetic variants associated with serum alanine aminotransferase levels among patients with hepatitis C virus infection: A genome-wide association study.”, Journal of viral hepatitis, 00, 1-9. (SCIE)
Wu Meei-Maan, Hsieh Fang-I, Hsu Ling-I, Lee Te-Chang, Chiou Hung-Yi, Chen Chien-Jen, 2021, “GT-Repeat Polymorphism in the HO-1 Gene Promoter Is Associated with Risk of Liver Cancer: A Follow-Up Study from Arseniasis-Endemic Areas in Taiwan”, Journal of Clinical Medicine, 10(7), 1489. (SCIE)
NCD Risk Factor Collaboration NCD-RisC, 2021, “Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight.”, eLife, 10, e60060. (SCIE)
Liu Z, Huang CJ, Huang YH, Pan MH, Lee MH, Yu KJ, Pfeiffer RM, Viard M, Yuki Y, Gao X, Carrington M, Chen CJ, Hildesheim A, Yang HI, 2021, “HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma.”, Journal of Infectious Diseases, 224(10), 1796-1805. (SCIE)
Koshiol J, Argirion I, Liu Z, Kim Lam T, O'Brien TR, Yu K, McGlynn KA, Petrick JL, Pinto L, Chen CJ, Hildesheim A, Pfeiffer RM, Lee MH, Yang HI, 2021, “Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.”, Alimentary pharmacology & therapeutics, 00, 1-10. (SCIE)
Liu Z, Derkach A, Yu KJ, Yeager M, Chang YS, Chen CJ, Gyllensten U, Lan Q, Lee MH, McKay JD, Rothman N, Yang HI, Hildesheim A, Pfeiffer RM, 2021, “Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer.”, Cancer Research, 81(4), 1148-1152. (SCIE)
Liao SF, Koshiol J, Huang YH, Jackson SS, Huang YH, Chan C, Huang C, Liu PC, Chen YJ, Hsieh RJ, Huang CP, Lu SN, Chen CJ, Shen CY, Lee MH, 2021, “Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.”, HEPATOLOGY, 0, 1-13. (SCIE)
Liang SK, Chien LH, Chang GC, Tsai YH, Su WC, Chen YM, Huang MS, Lin HC, Fang WT, Hung HH, Jiang SS, Chen CY, Chen KY, Chang IS, Hsiung CA, Chen CJ, Yang PC, 2021, “Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers.”, Frontiers in oncology, 11, 753788. (SCIE)
Wu HC, Yang HI, Lin PH, Chen CJ, Santella RM, Terry MB, 2021, “Reproductive and environmental exposures and the breast cancer risk in Taiwanese women.”, Scientific reports, 11(1), 15656. (SCIE)
Lin JH, Wen CP, Jiang CQ, Yuan JM, Chen CJ, Ho SY, Gao W, Zhang W, Wang R, Chien YC, Xu L, Wu X, Jin YL, Koh WP, Hsu WL, Zhu F, Wen C, Zhu T, Lee JH, Mai ZM, Lung ML, Lam TH, 2021, “Smoking and nasopharyngeal cancer: individual data meta-analysis of six prospective studies on 334 935 men.”, International Journal of Epidemiology, 20(3), 975-986. (SCIE)
Blechter B, Wong JYY, Agnes Hsiung C, Hosgood HD, Yin Z, Shu XO, Zhang H, Shi J, Song L, Song M, Zheng W, Wang Z, Caporaso N, Burdette L, Yeager M, Berndt SI, Teresa Landi M, Chen CJ, Chang GC, Hsiao CF, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Chien LH, Chen CH, Yang TY, Wang CL, Hung JY, Lin CC, Perng RP, Chen CY, Chen KC, Li YJ, Yu CJ, Chen YS, Chen YH, Tsai FY, Jie Seow W, Bassig BA, Hu W, Ji BT, Wu W, Guan P, He Q, Gao YT, Cai Q, Chow WH, Xiang YB, Lin D, Wu C, Wu YL, Shin MH, Hong YC, Matsuo K, Chen K, Pik Wong M, Lu D, Jin L, Wang JC, Seow A, Wu T, Shen H, Fraumeni JF, Yang PC, Chang IS, Zhou B, Chanock SJ, Rothman N, Chatterjee N, Lan Q, 2021, “Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia.”, ENVIRONMENT INTERNATIONAL, 147, 105975. (SCIE)
, Razavi Homie, Blach Sarah, Razavi-Shearer Devin, Abaalkhail Faisal, Abbas Zaigham, Abdallah Ayat, Abrao Ferreira Paulo, Abu Raddad Laith Jamal, Adda Danjuma, Agarwal Kosh, Aghemo Alessio, Ahmed Aijaz, Al‐Busafi Said A, Al‐hamoudi Waleed, Al‐Kaabi Saad, Al‐Romaihi Hamad, Aljarallah Badr, AlNaamani Khalid, Alqahtani Saleh, Alswat Khalid, Altraif Ibrahim, Asselah Tarik, Bacon Bruce, Bessone Fernando, Bizri Abdul Rahman, Block Tim, Bonino Ferruccio, Brandão‐Mello Carlos Eduardo, Brown Kimberly, Bruggmann Philip, Brunetto Maurizia Rossana, Buti Maria, Cabezas Joaquín, Calleja Jose Luis, Castro Batänjer Erika, Chan Henry Lik‐Yuen, Chang Henry, Chen Chien‐Jen, Christensen Peer Brehm, Chuang Wan‐Long, Cisneros Laura, Cohen Chari, Colombo Massimo, Conway Brian, Cooper Curtis, Craxi Antonio, Crespo Javier, Croes Esther, Cryer Donna, Cupertino de Barros Fernando Passos, Derbala Moutaz, Dillon John, Doss Wahid, Dou Xiaoguang, Doyle Joseph, Duberg Ann‐Sofi, Dugan Ellen, Dunn Rick, Dusheiko Geoffrey, El Khayat Hisham, El‐Sayed Manal H, Eshraghian Ahad, Esmat Gamal, Esteban Mur Rafael, Ezzat Sameera, Falconer Karolin, Fassio Eduardo, Ferrinho Paulo, Flamm Steven, Flisiak Robert, Foster Graham, Fung James, García‐Samaniego Javier, Gish Robert G, Gonçales Fernando, Halota Waldemar, Hamoudi Waseem, Hassany Mohamed, Hatzakis Angelos, Hay Susan, Himatt Sayed, Hoepelman I. M., Hsu Yao‐Chun, Hui Yee Tak, Hunyady Bela, Jacobson Ira, Janjua Naveed, Janssen Harry, Jarcuska Peter, Kabagambe Kenneth, Kanto Tatsuya, Kao Jia‐Horng, Kaymakoglu Sabahattin, Kershenobich David, Khamis Faryal, Kim Dong Joon, Kim Do Young, Kondili Loreta A, Kottilil Shyamasundaran, Kramvis Anna, Kugelmas Marcelo, Kurosaki Masayuki, Lacombe Karine, Lagging Martin, Lao Wai‐Cheung, Lavanchy Daniel, Lazarus Jeffrey V., Lee Alice, Lee Samual S, Levy Miriam, Liakina Valentina, Lim Young‐Suk, Liu Shuang, Maddrey Willis, Malekzadeh Reza, Marinho Rui Tato, Mathur Poonam, Maticic Mojca, Mendes Correa Maria Cassia, Mera Jorge, Merat Shahin, Mogawer Sherif, Mohamed Rosmawati, Muellhaupt Beat, Muljono David, Mostafa Ibrahim, Nahum Mendez Sanchez, Nawaz Arif, Negro Francesco, Ninburg Michael, Ning Qing, Ntiri‐ Reid Boatemaa, Nymadawa Pagbajabyn, Oevrehus Anne, Ormeci Necati, Orrego Mauricio, Osman Alaa, Oyunsuren Tsendsuren, Pan Calvin, Papaevangelou Vassiliki, Papatheodoridis George, Popping Stephanie, Prasad Papu, Prithiviputh Rittoo, Qureshi Huma, Ramji Alnoor, Razavi‐Shearer Kathryn, Reddy Rajender, Remak William, Richter Clemens, Ridruejo Ezequiel, Robaeys Geert, Roberts Stuart, Roberts Lewis, Roudot‐Thoraval Françoise, Saab Sammy, Said Sanaa, Salamat Amjad, Sanai Faisal, Sanchez‐Avila Juan Francisco, Schiff Eugene, Schinazi Raymond, Sebastiani Giada, Seguin‐Devaux Carole, Shanmugam R. P., Sharara Ala, Shilton Sonjelle, Shouval Daniel, Sievert William, Simonova Marieta, Sohrabpour Amir Ali, Sonderup Mark, Soza Alejandro, Wendy Spearman C, Steinfurth Nancy, Sulkowski Mark, Tan Soek‐Siam, Tanaka Junko, Tashi Dhondup, Thein Hla‐Hla, Thompson Peyton, Tolmane Ieva, Toy Mehlika, Valantinas Jonas, Van de Vijver David, Vélez‐Möller Patricia, Vince Adriana, Waked Imam, Wang Su, Wedemeyer Heiner, Wong Vincent, Xie Qing, Yamada Seiji, Yang Hwai‐I, Yesmembetov Kakharman, Yilmaz Yusuf, Younossi Zobair, Yu Ming‐Lung, Yuen Man‐Fung, Yurdaydin Cihan, Yusuf Aasim, Zekry Amany, Zeuzem Stefan, 2021, “The case for simplifying and using absolute targets for viral hepatitis elimination goals”, Journal of Viral Hepatitis, 28(1), 12-19. (SCIE)
NCD Risk Factor Collaboration NCD-RisC, 2021, “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.”, Lancet (London, England), 398(10304), 957-980.
Hsiao, Michael
Chan MH, Chen BG, Ngo LT, Huang WT, Li CH, Liu RS, Hsiao M*, 2021, “Natural Carbon Nanodots: Toxicity Assessment and Theranostic Biological Application [INVITED REVIEW]”, PHARMACEUTICS, Nov 5;13(11), 1874. (SCIE)
Lin MY, Chang YC, Wang SY, Yang MH, Chang CH, Hsiao M, Kitsis RN, Lee YJ, 2021, “OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer.”, ANTIOXIDANTS, Nov. 14;10(11), 1808. (SCIE)
Wen YC, Liu YN, Yeh HL, Chen WH, Jiang KC, Lin SR, Huang J, Hsiao M, Chen WY*, 2021, “TCF7L1 Regulates Cytokine Response and Neuroendocrine Differentiation of Prostate Cancer”, ONCOGENESIS, Nov 20;10(11), 81. (SCIE)
Yeh YC, Lawal B, Hsiao M, Huang TH, Huang CF, 2021, “Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates.”, BIOMEDICINES, Oct 30;9(11), 1582. (SCIE)
Chan MH, Lu CN, Chung YL, Chang YC, Li CH, Chen CL, Wei DH, Hsiao M*, 2021, “Magnetically Guided Theranostics: Montmorillonite-based Iron/platinum Nanoparticles for Enhancing In Situ MRI Contrast and Hepatocellular Carcinoma Treatment”, JOURNAL OF NANOBIOTECHNOLOGY, Oct 9;19(1), 308. (SCIE)
Pai S, Yadav VK, Kuo KT, Pikatan NW, Lin CS, Chien MH, Lee WH, Hsiao M, Chiu SC, Yeh CT, Tsai JT, 2021, “PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.”, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Oct. 25;22(21), 11492. (SCIE)
Tsai HF, Chang YC, Li CH, Chan MH, Chen CL, Tsai WC, Hsiao M*, 2021, “Type V Collagen Alpha 1 Chain Promotes the Malignancy of Glioblastoma through PPRC1-ESM1 Axis Activation and Extracellular Matrix Remodeling”, CELL DEATH DISCOVERY, Oct. 26;7(1), 313. (SCIE)
Wu ATH, Huang HS, Wen YT, Lawal B, Mokgautsi N, Huynh TT, Hsiao M, Wei L, 2021, “A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.”, CELLS, Sep 11;10(9), 2391. (SCIE)
Chen TH, Chen YJ, Huang TS, Hsiao M, Lin CC, Liu YP, 2021, “Does Positive Feeling Lead to More Impulsiveness? - Implication of Previous Rewarded Experience on Location-dependent Motoric Impulsivity”, CHINESE JOURNAL OF PHYSIOLOGY, 64(5), 218-224. (SCIE)
Li CH, Chang YC, Chan MH, Yang YF, Liang SM, Hsiao M*, 2021, “Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives [INVITED REVIEW]”, BIONMEDICINES, Sep 4;9(9), 1159.
Li CH, Hsu TI, Chang YC, Chan MH, Lu PJ, Hsiao M*, 2021, “Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis [INVITED REVIEW]”, BIOMEDICINES, Sep 18;9(9), 1265. (SCIE)
Chi LH, Wu ATH, Hsiao M*, Li YC, 2021, “A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications”, JOURNAL OF PERSONALIZED MEDICINE, 11(8), 782. (SCIE)
Kuo KT, Yeh CT, Chen TT, Satriyo PB, Wang CH, Wu ATH, Chao TY, Lee KY, Hsiao M, Wang LS, 2021, “Bruton’s Tyrosine Kinase (BTK) Mediates Resistance to EGFR Inhibition in Non-Small Cell Lung Cancer”, ONCOGENESIS, 10(7), 56. (SCIE)
Hsu HJ, Tung CP, Yu CM, Chen CY, Chen HS, Huang YC, Tsai PH, Lin SI Peng HP, Chiu YK, Tsou YL, Kuo WY, Jian JW, Hung FH, Hsieh CY, Hsiao M, Chuang SS, Shen CN, Wang YA, Yang AS, 2021, “Eradicating Mesothelin-positive Human Gastric and Pancreatic Tumors in Xenograft Models with Optimized Anti-mesothelin Antibody–drug Conjugates from Synthetic Antibody Libraries”, SCIENTIFIC REPORTS, 11(1), 15430. (SCIE)
Chang YC, Chan MH, Li CH, Fang CY, Hsiao M*, Chen CL, 2021, “Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers [INVITED REVIEW]”, BIOMEDICINES, 9(8), 931. (SCIE)
Chung SY, Hung YP, Pan YR, Chang YC, Wu CE, Hsu DS, Chang PM, Lu ML, Huang CY, Su Y, Hsiao M, Yeh CN, Chen MH, 2021, “Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway”, BIOMEDICINES, 9(8), 885. (SCIE)
Chan MH, Chen W, Li CH, Fang CY, Chang YC, Wei DH, Liu RS, Hsiao M*, 2021, “An Advanced In Situ Magnetic Resonance Imaging and Ultrasonic Theranostics Nanocomposite Platform: Crossing the Blood–Brain Barrier and Improving the Suppression of Glioblastoma Using Iron-Platinum Nanoparticles in Nanobubbles”, ACS APPLIED MATERIALS & INTERFACES, Jun 16;13(23), 26759-26769. (SCIE)
Chang YC, Chan MH, Li CH, Yang CJ, Tseng YW, Tsai HF, Chiou J, Hsiao M*, 2021, “Metabolic Protein Phosphoglycerate Kinase 1 Confers Lung Cancer Migration by Directly Binding to HIV Tat Specific Factor 1”, CELL DEATH DISCOVERY, Jun 5;7(1), 135. (SCIE)
Yuan LT, Lee WJ, Yang YC, Chen BR, Yang CY, Chen MW, Chen JQ, Hsiao M, Chien MH, Hua KT, 2021, “Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122”, CANCERS, 13(10), 2376. (SCIE)
Yang YC, Chien MH, Lai TC, Tung MC, Jan YH, Chang WM, Jung SM, Chen MH, Yeh CN, Hsiao M*, 2021, “Proteomics-based Identification of TMED9 Is Linked to Vascular Invasion and Poor Prognoses in Patients with Hepatocellular Carcinoma”, JOURNAL OF BIOMEDICAL SCIENCE, Apr 22;28(1), 29. (SCIE)
Lin TC, Hsiao M*, 2021, “Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments - [INVITED REVIEW]”, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Mar 11;22(6), 2870. (SCIE)
Pan JK, Lin CH, Kuo YL, Ger LP, Cheng HC, Yao YC, Hsiao M, Lu PJ, 2021, “MiR-211 Determines Brain Metastasis Specificity through SOX11/NGN2 Axis in Triple-negative Breast Cancer”, ONCOGENE, Mar;40(9):1737, 1751. (SCIE)
Huang WT, Su TY, Chan MH, Tsai JY, Do YY, Huang PL, Hsiao M*, Liu RS, 2021, “Near-infrared Nanophosphor Embedded in Mesoporous Silica Nanoparticle with High Light-Harvesting Efficiency to Promote Dual Photosystem”, ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, Mar 22;60(13):6955, 6959. (SCIE)
Chuang HH, Zhen YY, Tsai YC, Chuang CH, Huang MS, Hsiao M*, Yang CJ, 2021, “Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy - [INVITED REVIEW]”, BIOMEDICINES, Mar 31;9(4), 359. (SCIE)
Li LJ, Chang WM, Hsiao M*, 2021, “Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts - [INVITED REVIEW]”, PHARMACEUTICALS, Feb 27;14(3), 194. (SCIE)
Chen CL, Chen CC, Yu WH, Chen SH, Chang YC, Hsu TI, Hsiao M, Yeh CY, Chen CY, 2021, “An Annotation-free Whole-slide Training Approach to Pathological Classification of Lung Cancer Types using Deep Learning”, NATURE COMMUNICATIONS, Feb 19;12(1), 1193. (SCIE)
Pan KF, Lee WJ, Chou CC, Yang YC, Chang YC, Chien MH, Hsiao M, Hua KT, 2021, “Direct Interaction of β‐catenin with Nuclear ESM1 Supports Stemness of Metastatic Prostate Cancer”, EMBO JOURNAL, Feb15;40(4), e105450. (SCIE)
Cheng CL, Chan MH, Feng SJ, Hsiao M*, Liu RS, 2021, “Long-Term Near-Infrared Signal Tracking of the Therapeutic Changes of Glioblastoma Cells in Brain Tissue with Ultrasound-Guided Persistent Luminescent Nanocomposites”, ACS APPLIED MATERIALS & INTERFACES, Feb 10;13(5), 6099-6108. (SCIE)
Chen WY, Wen YC, Lin SR, Yeh HL, Jiang KC, Chen WH, Lin YS, Zhang Q, Liew PL, Hsiao M, Huang J, Liu YN, 2021, “Nerve Growth Factor Interacts with CHRM4 and Promotes Neuroendocrine Differentiation of Prostate Cancer and Castration Resistance”, COMMUNICATIONS BIOLOGY, Jan 4;4(1), 22. (SCIE)
Hsieh, Shie-Liang
Sun CP, Jan JT, Wang IH, Ma HH, Ko HY, Wu PY, Kuo TJ, Liao HN, Lan YH, Sie ZL, Chen YH, Ko YA, Liao CC, Chen LY, Lee IJ, Tsung SI, Lai YJ, Chiang MT, Liang JJ, Liu WC, Wang JR, Yuan PY, Lin YS, Tsai YC, Hsieh SL, Li CW, Wu HC, Ko TM, Lin YL, Tao MH*, 2021, “Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19”, PLOS PATHOGENS, 17(8):, e1009758. (SCIE)
Sung PS, Hsieh SL*, 2021, “C-type lectins and extracellular vesicles in virus-induced NETosis”, JOURNAL OF BIOMEDICAL SCIENCE, 28(1), 46. (SCIE)
Tsai TY, Huang MT, Sung PS, Peng CY, Tao MH, Yang HI, Chang WC, Yang AS, Yu CM, Lin YP, Ching-Yu Bau3, Huang CJ, Pan MH, Wu CY, Hsiao CD, Yeh YH, Shiteng Duan, James C Paulson, Hsieh SL*, 2021, “Siglec-3 (CD33) is the immune checkpoint receptor in HBV infection”, JOURNAL OF CLINICAL INVESTIGATION, 131(11), 141965. (SCIE)
Pan YG, Huang MT, P. Sekar, Huang DY, Lin WW, Hsieh SL*, 2021, “Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation via Reduction of Reactive Oxygen Species Production and Lysosomal Rupture”, FRONTIERS IN IMMUNOLOGY, 12: 638676, 1-16. (SCIE)
Huang YL , Huang MT, Sung PS, Chou TY, Yang RB, Yang AS, Yu CM, Hsu YW, Chang WC, Hsieh SL*, 2021, “Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection”, Communications biology, 4(1): 229, 1-13. (SCIE)
Hwang-Verslues, Wendy W.
Chen L.C., Hsieh Y.L., Tan G.Y.T., Kuo T.Y., Chou Y.C., Hsu P.H., Hwang-Verslues W.W.*, 2021, “Differential Effects of SUMO1 and SUMO2 on Circadian Protein PER2 Stability and Function”, SCIENTIFIC REPORTS, 11, 14431. (SCIE)
Chang P.H., Chen M.C., Tsai Y.P., Tan G.Y.T., Hsu P.H., Jeng Y.M., Tsai Y.F., Yang M.H., Hwang-Verslues W.W.*, 2021, “Interplay between Desmoglein2 and hypoxia controls metastasis in breast cancer”, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 118(3), e2014408118. (SCIE)
Ko, Y.-A., Yu, Y.-H., Wu, Y.-F., Tseng, Y.-C., Chen, C.-L., Goh, K.-S, Liao, H.-Y., Chen, T.-H., Cheng, R. T.-J., Yang, A.-S., Wong, C.-H., Ma, C. and Lin, K.-I*, 2021, “A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells”, PLOS PATHOGENS, 17(8), e1009724. (SCIE)
Lo, L.-W., Chang, C.-W., Chiang, M.-F., Lin, I-Y., and Lin, K.-I*, 2021, “Marginal zone B cells assist with neutrophil accumulation to fight against systemic Staphylococcus aureus infection”, FRONTIERS IN IMMUNOLOGY, 12, 636818. (SCIE)
Lee, W., Wang, L.-T., Yen, M.-L., Hsu, P.-J., Lee, Y.-W., Liu, K.-J., Lin, K.-I, Su, Y.-W., Sytwu, H.-K., and Yen, B. L., 2021, “Resident vs. nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes”, Stem Cells Transi Med, 10(5), 711-724.
Lu, Joyce Jean
Lin PY, Yang D, Chuang CH, Lin H, Chen WJ, Chen CY, Chuang TJ, Lai CY, Li LY, Schuyler SC, Lu FL, Liu YC, Lu J*, 2021, “Comparative analyses of single-cell transcriptomic profiles between In vitro totipotent blastomere-like cells and In vivo early mouse embryonic cells”, CELLS, 10(11), 3111. (SCIE)
Lai YP, Kuo LC, Lin BR, Lin HJ, Lin CY, Chen YT, Hsiao PW, Chang HT, Ko PC, Chen HC, Chang HY, Lu J, Ho HN, Wu-Hsieh BA, Kung JT, Chen SC, 2021, “CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells.”, Communications biology, 4(1), 595. (SCIE)
Shen, Chia-Ning
C.W. Lin, Y.J. Wang, T.Y. Lai, T.L. Hsu, S.Y. Han, H.C. Wu, C.N. Shen, V. Dang, M.W. Chen, L.B. Chen, C.H. Wong*, 2021, “Homogeneous antibody and CAR-T cell with improved effector functions targeting SSEA-4 glycan on pancreatic cancer”, Proceedings of The National Academy of Sciences of the United States of America, 118(50), e2114774118. (SCIE)
Hsu HJ, Tung CP, Yu CM, Chen CY, Chen HS, Huang YC, Tsai PH, Lin SI, Peng HP, Chiu YK, Tsou YL, Kuo WY, Jian JW, Hung FH, Hsieh CY, Hsiao M, Chuang SS, Shen CN, Wang YA, Yang AS, 2021, “Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody libraries.”, Scientific reports, 11(1), 15430. (SCIE)
Wu, H.H., L.H. Tsai, C.K. Huang, S.C. Huang, P.H. Hsu, M.Y. Chen, Y.I. Chen, C.M. Hu, C.N.Shen, C.C. Lee, M.C. Chang, Y.T. Chang, Y.W. Tien, Y.M. Jeng, E. Lee, and W.H. Lee*, 2021, “Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer”, Science Translational Medicine, 13, eabc2823. (SCIE)
Yang, Hwai-I
Wei SC, Hsu WT, Chiu CH, Chang FY, Lo HR, Liao CY, Yang HI, Chou YC, Tsai CH, Chao YC, 2021, “An Integrated Platform for Serological Detection and Vaccination of COVID-19.”, FRONTIERS IN IMMUNOLOGY, 12, 771011. (SCIE)
Li Jie, Yang Hwai-I, Yeh Ming-Lun, Le Michael H, Le An K, Yeo Yee Hui, Dai Chia-Yen, Barnett Scott, Zhang Jian Q, Huang Jee-Fu, Trinh Huy N, Wong Christopher, Wong Clifford, Hoang Joseph K, Cheung Ramsey, Yu Ming-Lung, Nguyen Mindie H, 2021, “Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B”, The Journal of Infectious Diseases, 224 (2) , 294-302. (SCIE)
Argirion I, Pfeiffer RM, Lam TK, O'Brien TR, Yu K, McGlynn KA, Petrick JL, Pinto L, Chen CJ, Lee MH, Hildesheim A, Yang HI, Koshiol J, 2021, “Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B.”, Scientific reports, 11(1), 21194. (SCIE)
Pan WC*, Yeh SY, Wu CD, Huang YT, Chen YC, Chen CJ, Yang HI*, 2021, “Association between Traffic Count and Cardiovascular Mortality: A Prospective Cohort Study in Taiwan.”, JOURNAL OF EPIDEMIOLOGY, 31(5), 343-349. (SCIE)
Le AK, Yang HI, Yeh ML, Jin M, Trinh HN, Henry L, Liu A, Zhang JQ, Li J, Wong C, Wong C, Cheung R, Yu ML, Nguyen MH, 2021, “Development and validation of a risk score for liver cirrhosis prediction in untreated and treated chronic hepatitis B.”, JOURNAL OF INFECTIOUS DISEASES, 223(1), 139-146. (SCIE)
Yang HI*, Hsu YC, 2021, “Editorial: incorporating liver stiffness to risk scores for HCC in patients with chronic hepatitis B treated with oral antivirals: ready to use or not?”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 53(6), 753-754. (SCIE)
Chen Chien-Jen, You San-Lin, Hsu Wan-Lun, Yang Hwai-I, Lee Mei-Hsuan, Chen Hui-Chi, Chen Yun-Yuan, Liu Jessica, Hu Hui-Han, Lin Yu-Ju, Chu Yu-Ju, Huang Yen-Tsung, Chiang Chun-Ju, Chien Yin-Chu, 2021, “Epidemiology of Virus Infection and Human Cancer”, Recent Results Cancer Res, 217, 13-45.
Wang Z, Budhu AS, Shen Y, Wong LL, Hernandez BY, Tiirikainen M, Ma X, Irwin ML, Lu L, Zhao H, Lim JK, Taddei T, Mishra L, Pawlish K, Stroup A, Brown R, Nguyen MH, Koshiol J, Hernandez MO, Forgues M, Yang HI, Lee MH, Huang YH, Iwasaki M, Goto A, Suzuki S, Matsuda K, Tanikawa C, Kamatani Y, Mann D, Guarnera M, Shetty K, Thomas CE, Yuan JM, Khor CC, Koh WP, Risch H, Wang XW, Yu H, 2021, “Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.”, JGH open, 5(12), 1363-1372.
Wu S, Zeng N, Sun F, Zhou J, Wu X, Sun Y, Wang B, Zhan S, Kong Y, Jia J, You H*, Yang HI*, 2021, “Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation.”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 19(12), 2499-2513. (SCIE)
Liu Z, Huang CJ, Huang YH, Pan MH, Lee MH, Yu KJ, Pfeiffer RM, Viard M, Yuki Y, Gao X, Carrington M, Chen CJ*, Hildesheim A*, Yang HI*, 2021, “HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma.”, JOURNAL OF INFECTIOUS DISEASES, 224(10), 1796-1805. (SCIE)
Koshiol J, Argirion I, Liu Z, Kim Lam T, O'Brien TR, Yu K, McGlynn KA, Petrick JL, Pinto L, Chen CJ, Hildesheim A, Pfeiffer RM, Lee MH, Yang HI, 2021, “Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.”, Alimentary pharmacology & therapeutics, 54(6), 833-842. (SCIE)
Chung CW, Hsiao TH, Huang CJ, Chen YJ, Chen HH, Lin CH, Chou SC, Chen TS, Chung YF, Yang HI, Chen YM, 2021, “Machine learning approaches for the genomic prediction of rheumatoid arthritis and systemic lupus erythematosus.”, BioData mining, 14(1), 52. (SCIE)
Wu HC, Yang HI, Lin PH, Chen CJ, Santella RM, Terry MB, 2021, “Reproductive and environmental exposures and the breast cancer risk in Taiwanese women.”, Scientific reports, 11(1), 15656. (SCIE)
Teng W, Chang TT, Yang HI, Peng CY, Su CW, Su TH, Hu TH, Yu ML, Yang HC, Wu JC, 2021, “Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.”, Hepatology international, 15(6), 1421-1430. (SCIE)
Tsai TY, Huang MT, Sung PS, Peng CY, Tao MH, Yang HI, Chang WC, Yang AS, Yu CM, Lin YP, Bau CY, Huang CJ, Pan MH, Wu CY, Hsiao CD, Yeh YH, Duan S, Paulson JC, Hsieh SL, 2021, “SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection.”, The Journal of clinical investigation, 131(11), e141965. (SCIE)
Polaris Observatory Collaborators, 2021, “The case for simplifying and using absolute targets for viral hepatitis elimination goals.”, JOURNAL OF VIRAL HEPATITIS, 28(1), 12-19. (SCIE)
Liu Matt, Tseng Tai-Chung, Jun Dae Won, Yeh Ming-Lun, Trinh Huy, Wong Grace L. H., Chen Chien-Hung, Peng Cheng-Yuan, Kim Sung Eun, Oh Hyunwoo, Kwak Min-Sun, Cheung Michael, Toyoda Hidenori, Hsu Yao-Chun, Jeong Jae Yoon, Yoon Eileen L., Ungtrakul Teerapat, Zhang Jian, Xie Qing, Ahn Sang Bong, Enomoto Masaru, Shim Jae-Jun, Cunningham Chris, Jeong Soung Won, Cho Yong Kyun, Ogawa Eiichi, Huang Rui, Lee Dong-Hyun, Takahashi Hirokazu, Tsai Pei-Chien, Huang Chung-Feng, Dai Chia-Yen, Tseng Cheng-Hao, Yasuda Satoshi, Kozuka Ritsuzo, Li Jiayi, Wong Christopher, Wong Clifford C., Zhao Changqing, Hoang Joseph, Eguchi Yuichiro, Wu Chao, Tanaka Yasuhito, Gane Ed, Tanwandee Tawesak, Cheung Ramsey, Yuen Man-Fung, Lee Hyo-Suk, Yu Ming-Lung, Kao Jia-Horng, Yang Hwai-I, Nguyen Mindie H., 2021, “Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients”, Hepatology International, 15(1), 71-81. (SCIE)